Featured Pharma Online Editorial
-
Chugai Accelerates Automation To Boost Operational Efficiency
6/3/2026
What do you do when tasked with producing drugs of different molecular sizes, including highly potent compounds, in the same facility on a global scale? You tap technological advances in automation, modular design for flexibility, and tie it together with systems that enable real-time data.
-
Applying Contamination Control By Design: A Practical Guide For CDMOs
5/26/2026
This article addresses the three contamination control challenges that are specific to the CDMO environment, provides five practical steps any organization can act on now, and more.
-
Navigating Rough Pharma Seas With Collaboration
5/22/2026
Facing geopolitical, regulatory, and operational complexity, pharma leaders are rethinking supply chains, embracing AI, and simplifying processes. Progress hinges on cross-industry collaboration and shared standards to build resilient, efficient systems.
-
[Video] Get It Right with The Gemba
5/8/2026
The idea of the Gemba walk originated after World War II in Japan, specifically in relation to automotive production at Toyota. The word can be translated to “the real or actual place,” referring to where the work takes place—in the case of pharma or automobiles, on the factory floor.
-
Making Mental Health Drugs: Promising Therapies And Manufacturing Challenges
4/30/2026
Psychedelic therapies have shown promise in treating mental health disorders, but it will take close collaboration and cooperation of all related agencies and manufacturers to make this promise a reality.
-
A 5-Step Foundation For Early CQV Involvement
4/28/2026
All too often, a project’s issues show up in CQV, and it is there that blame is pointed. However, these issues start earlier and are entirely avoidable with proper planning.
-
Building Quality Into Radiopharmaceuticals: A Look At EMA's Recent Guideline
4/28/2026
The EMA's December 2025 draft guideline on expectations for the quality documentation of radiopharmaceuticals replaces the earlier 2007 guideline and reflects significant developments.
-
Challenges And Solutions In Aseptic Evolution
4/22/2026
Aseptic processing has undergone a considerable evolution over the past 35 years in new equipment, standards, procedures, training and regulation. Navigating these challenges is essential to minimizing risk.
-
The Hidden Operational Cost Contained In Every Small Molecule Portfolio
4/21/2026
The volume of post-approval changes is rising and the manual approaches that have worked until now are no longer adequate. Get ahead of this to spend less and execute faster.
-
From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations
4/6/2026
Learn what regulators are already asking about AI, what quality must mean in this new context, and how organizations can begin building the governance infrastructure.